Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents

Introduction: Chronic rhinosinusitis with nasal polyposis is a common pathology in Otorhinolaryngology, and the therapeutic options, in a simplified way, are medical and/or surgical. Medical therapeutic options, in addition to topical and oral corticosteroid therapy, include the use of biological a...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro Marques Gomes, Diogo Cunha Cabral, André Carção, Joana Barreto, Ana Isabel Gonçalves, Paula Azevedo, José Penêda, Delfim Duarte, Miguel Viana
Format: Article
Language:English
Published: Portuguese Society of Otolaryngology and Head and Neck Surgery 2023-08-01
Series:Revista Portuguesa Otorrinolaringologia e Cirurgia de Cabeça e Pescoço
Subjects:
Online Access:https://journalsporl.com/index.php/sporl/article/view/2038
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166061121404928
author Pedro Marques Gomes
Diogo Cunha Cabral
André Carção
Joana Barreto
Ana Isabel Gonçalves
Paula Azevedo
José Penêda
Delfim Duarte
Miguel Viana
author_facet Pedro Marques Gomes
Diogo Cunha Cabral
André Carção
Joana Barreto
Ana Isabel Gonçalves
Paula Azevedo
José Penêda
Delfim Duarte
Miguel Viana
author_sort Pedro Marques Gomes
collection DOAJ
description Introduction: Chronic rhinosinusitis with nasal polyposis is a common pathology in Otorhinolaryngology, and the therapeutic options, in a simplified way, are medical and/or surgical. Medical therapeutic options, in addition to topical and oral corticosteroid therapy, include the use of biological agents. Three biological agents were recently approved for the treatment of chronic rhinosinusitis with nasal polyposis in Portugal, being indicated in critically ill patients not controlled with topical nasal corticosteroid therapy, for whom surgery (unless contraindicated) and/or systemic corticosteroid therapy did not provide adequate control of the disease. Objectives: To propose a clinical evaluation protocol in patients under biological treatment. Methods: Review of relevant medical literature, namely the two main international working groups on this topic: European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS) and European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA). Results: The protocol created can be divided into 3 phases: an initial phase with collection of demographic and clinical data, a second phase with evaluation of eligibility for biologicals based on well-defined admission criteria and a third phase with a proposal of follow-up and application of efficacy and discontinuation criteria. Conclusion: This clinical protocol presents a proposition for the collection of standardized data to be used in clinical practice, which allows a uniform collection for carrying out prospective and/or retrospective multicenter studies, in addition to a proposition for follow-up and evaluation of the efficacy/failure of the treatment with biological agents, in patients with chronic rhinosinusitis with polyposis.
format Article
id doaj-art-d725b7d9243849fc8fa7e52a6094bf5c
institution OA Journals
issn 2184-6499
language English
publishDate 2023-08-01
publisher Portuguese Society of Otolaryngology and Head and Neck Surgery
record_format Article
series Revista Portuguesa Otorrinolaringologia e Cirurgia de Cabeça e Pescoço
spelling doaj-art-d725b7d9243849fc8fa7e52a6094bf5c2025-08-20T02:21:34ZengPortuguese Society of Otolaryngology and Head and Neck SurgeryRevista Portuguesa Otorrinolaringologia e Cirurgia de Cabeça e Pescoço2184-64992023-08-0161210.34631/sporl.2038Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agentsPedro Marques Gomes0Diogo Cunha Cabral1André Carção2Joana Barreto3Ana Isabel Gonçalves4Paula Azevedo5José Penêda6Delfim Duarte7Miguel Viana8Unidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, Portugal Unidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, PortugalUnidade Local de Saúde de Matosinhos – Hospital Pedro Hispano, Portugal Introduction: Chronic rhinosinusitis with nasal polyposis is a common pathology in Otorhinolaryngology, and the therapeutic options, in a simplified way, are medical and/or surgical. Medical therapeutic options, in addition to topical and oral corticosteroid therapy, include the use of biological agents. Three biological agents were recently approved for the treatment of chronic rhinosinusitis with nasal polyposis in Portugal, being indicated in critically ill patients not controlled with topical nasal corticosteroid therapy, for whom surgery (unless contraindicated) and/or systemic corticosteroid therapy did not provide adequate control of the disease. Objectives: To propose a clinical evaluation protocol in patients under biological treatment. Methods: Review of relevant medical literature, namely the two main international working groups on this topic: European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS) and European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA). Results: The protocol created can be divided into 3 phases: an initial phase with collection of demographic and clinical data, a second phase with evaluation of eligibility for biologicals based on well-defined admission criteria and a third phase with a proposal of follow-up and application of efficacy and discontinuation criteria. Conclusion: This clinical protocol presents a proposition for the collection of standardized data to be used in clinical practice, which allows a uniform collection for carrying out prospective and/or retrospective multicenter studies, in addition to a proposition for follow-up and evaluation of the efficacy/failure of the treatment with biological agents, in patients with chronic rhinosinusitis with polyposis. https://journalsporl.com/index.php/sporl/article/view/2038Chronic rhinosinusitis with polyposisBiological AgentsClinical Protocol
spellingShingle Pedro Marques Gomes
Diogo Cunha Cabral
André Carção
Joana Barreto
Ana Isabel Gonçalves
Paula Azevedo
José Penêda
Delfim Duarte
Miguel Viana
Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
Revista Portuguesa Otorrinolaringologia e Cirurgia de Cabeça e Pescoço
Chronic rhinosinusitis with polyposis
Biological Agents
Clinical Protocol
title Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
title_full Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
title_fullStr Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
title_full_unstemmed Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
title_short Clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
title_sort clinical evaluation protocol for chronic rhinosinusitis with polyposis during treatment with biological agents
topic Chronic rhinosinusitis with polyposis
Biological Agents
Clinical Protocol
url https://journalsporl.com/index.php/sporl/article/view/2038
work_keys_str_mv AT pedromarquesgomes clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT diogocunhacabral clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT andrecarcao clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT joanabarreto clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT anaisabelgoncalves clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT paulaazevedo clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT josepeneda clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT delfimduarte clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents
AT miguelviana clinicalevaluationprotocolforchronicrhinosinusitiswithpolyposisduringtreatmentwithbiologicalagents